Top compounds associated with response to SLC22A13


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan CCLE pan-cancer AAC -0.037 0.4
mRNA birinapant CTRPv2 pan-cancer AAC -0.033 0.4
mRNA valdecoxib CTRPv2 pan-cancer AAC -0.031 0.4
mRNA KU-60019 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA AM-580 CTRPv2 pan-cancer AAC -0.033 0.4
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.032 0.4
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.032 0.4
mRNA pluripotin CTRPv2 pan-cancer AAC -0.031 0.4
mRNA AT7867 CTRPv2 pan-cancer AAC -0.031 0.4
Download CSV